Urology News and Research

Latest Urology News and Research

Outcome of penile prosthesis implantation for treating erectile dysfunction

Nine out of ten men fitted with a penile prosthesis were able to have sexual intercourse and eight out of ten were satisfied with the overall results, according to research published in the latest issue of BJU International.

9 Jan 2006

Imatinib mesylate (Gleevec) may not be effective at treating kidney cancer

Mayo Clinic Cancer Center investigators report that imatinib mesylate (GleevecTM), the drug used to treat patients with gastrointestinal stromal cancers (GISTs), is not likely to be effective for patients with high grade renal cell carcinoma -- the most aggressive kidney cancer.

22 Dec 2005

Lifestyle factors affect prostate cancer tests

According to a new study a prostate cancer-screening test may not be that reliable.

12 Dec 2005

Viagra effectively treats urinary tract symptoms associated with prostate enlargement

Viagra (sildenafil citrate), known for improving erectile dysfunction (ED), also effectively treats the prostate and lower urinary tract symptoms (LUTS) associated with prostate enlargement that often occur with ED, a Northwestern University study has found.

21 Nov 2005

Speed of PSA increase matters more than PSA level

In the largest study of its kind to date, Mayo Clinic researchers report that prostate specific antigen (PSA) kinetics, both velocity and doubling time, can be used to predict disease progression and likelihood of death after radical prostatectomy surgery, suggesting that this could be used to guide treatment decisions.

14 Nov 2005

Zyflamend shows promise in the early treatment of prostate cancer

Data from the Columbia University Department of Urology demonstrates that Zyflamend, a unique herbal extract preparation, suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct via a process called "apoptosis."

13 Nov 2005

Role of alpha tocopherol associated protein in prostate cancer

Researchers have identified a protein that disrupts an important signaling pathway in prostate cancer cells and suppresses growth of the cancer.

1 Nov 2005

Gene fusion appears to cause prostate cancer

Scientists at the University of Michigan Medical School, in collaboration with researchers at Harvard's Brigham and Women's Hospital, have discovered a recurring pattern of scrambled chromosomes and abnormal gene activity that occurs only in prostate cancer.

30 Oct 2005

Needle free vasectomy

A new anesthetic technique for vasectomy that does not involve the use of needles has been shown to be safe and effective, according to a recent study presented by Dr. Marc Goldstein of NewYork-Presbyterian Hospital/Weill Cornell Medical Center's Department of Urology.

27 Oct 2005

As men grow older, bladder function can worsen and the prostate gland may be responsible

Their findings remind patients and their physicians that urination difficulties in men can be better cared for at early onset. Additionally, the study notes that as men age, the possibility increases that they will experience problems with urination.

25 Oct 2005

New treatments suggest that cancer is on the run!

People suffering from cancer will be encouraged by a cluster of recent reports on successful new treatments for several different forms of cancer.

24 Oct 2005

Diet rich in fruits and vegetables could be a good defense against prostate cancer

Previous studies have suggested that increased intake of flavonoids which are common in fruits and vegetables may be associated with a reduced risk of prostate cancer, according to Sanjay Gupta, Ph.D., an assistant professor in the Case School of Medicine Department of Urology.

20 Oct 2005

Men who smoke cigarettes may experience a significant decline in their capacity to father a child

Sperm from nearly two-thirds of the chronic smokers in the study failed a special test that measures the ability of sperm to fertilize an egg. On average, those men showed a 75 percent decline in fertilizing capacity when compared to nonsmokers. Lead researcher Loni Burkman, Ph.D., presented the results today (Oct. 17, 2005) at the American Society of Reproductive Medicine annual meeting in Montreal, Quebec.

17 Oct 2005

1G8 antibody signals prostate cancer cells to stop growing and die

Researchers at UCLA's Jonsson Cancer Center have uncovered the mechanism by which an antibody blocks the growth of prostate cancer in animal models, a discovery that could pave the way for development of a new molecularly targeted therapy.

17 Oct 2005

Microfluidics can be used successfully for IVF in mice

Technology that more closely mirrors the natural fertilization process is showing promise as a new method of in-vitro fertilization, researchers at the University of Michigan Health System have found.

12 Oct 2005

Promising new treatment options for prostate cancer

Prostate cancer is the second leading cause of death among American men. It is estimated that one in six males will develop the disease during his lifetime. However, promising new treatment options have been developed to help combat this threatening disease.

9 Oct 2005

PSA remains the best measure of the likelihood of prostate cancer recurrence after surgery

Despite recent claims by some urologists that measuring the blood protein prostate-specific antigen (PSA) may not be effective in predicting risk of prostate cancer, a Johns Hopkins study of more than 2,000 men confirms that PSA remains the best measure of the likelihood of cancer recurrence after surgery.

19 Sep 2005

Low-fat, plant-based diet is more effective at helping women lose weight

A low-fat, plant-based diet is more effective at helping women lose weight and improve insulin sensitivity than an omnivorous diet, shows a new study appearing in the September issue of The American Journal of Medicine.

10 Sep 2005

Prostate cancer manipulates an important group of signaling proteins called Wnts to establish itself in bone

Prostate cancer is a cruel disease. Left untreated, prostate cancer cells often metastasize, or spread, to bone where they form fracture-prone tumors that are extremely painful.

1 Sep 2005

IP 751 a marijuana-derived drug effectively suppresses pain and bladder overactivity in hypersensitive bladder disorders

IP 751, a potent synthetic analog of a metabolite of THC-the principal active ingredient of marijuana-effectively suppresses pain and bladder overactivity in hypersensitive bladder disorders such as interstitial cystitis (IC), according to animal model study results presented today at the annual meeting of the International Continence Society.

1 Sep 2005